HealthEquity, Inc. (NASDAQ:HQY) Given Average Recommendation of "Buy" by Brokerages

Key Points

• HealthEquity, Inc. has received a consensus recommendation of "Buy" from thirteen ratings firms, with the average price target set at $119.77.
• Recent price targets set by analysts include $120.00 by Raymond James and $126.00 by JPMorgan Chase & Co., indicating strong confidence in the company's growth potential.
• Wealth Enhancement Advisory Services has increased its stake in HealthEquity by 24.7%, reflecting growing interest from institutional investors in the company.

Shares of HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) have been assigned an average rating of "Buy" from the thirteen brokerages that are covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $119.7692.

Several analysts recently issued reports on the company. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a research note on Friday, June 6th. Deutsche Bank Aktiengesellschaft boosted their price target on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, June 5th. JPMorgan Chase & Co. boosted their price target on HealthEquity from $125.00 to $126.00 and gave the company an "overweight" rating in a research note on Wednesday, September 3rd. Royal Bank Of Canada boosted their price target on HealthEquity from $109.00 to $110.00 and gave the company an "outperform" rating in a research note on Wednesday, September 3rd. Finally, Jefferies Financial Group boosted their price target on HealthEquity from $130.00 to $134.00 and gave the company a "buy" rating in a research note on Wednesday, September 3rd.

HealthEquity Stock Performance

HQY traded up $0.74 during trading on Friday, hitting $92.28. The stock had a trading volume of 737,118 shares, compared to its average volume of 1,215,614. The company has a 50 day moving average price of $92.90 and a 200-day moving average price of $94.19. The firm has a market cap of $7.95 billion, a price-to-earnings ratio of 55.93, a P/E/G ratio of 1.31 and a beta of 0.50. HealthEquity has a one year low of $74.07 and a one year high of $116.65. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23.

Insider Buying and Selling at HealthEquity

In other news, EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction on Monday, July 7th. The stock was sold at an average price of $101.73, for a total transaction of $182,503.62. Following the completion of the sale, the executive vice president directly owned 53,225 shares in the company, valued at approximately $5,414,579.25. This represents a 3.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 1.50% of the company's stock.

Institutional Trading of HealthEquity

A number of institutional investors have recently modified their holdings of HQY. Ameriprise Financial Inc. lifted its position in shares of HealthEquity by 56.4% during the 4th quarter. Ameriprise Financial Inc. now owns 270,042 shares of the company's stock valued at $25,911,000 after acquiring an additional 97,329 shares during the period. Cetera Investment Advisers lifted its position in shares of HealthEquity by 6.7% during the 4th quarter. Cetera Investment Advisers now owns 3,572 shares of the company's stock valued at $343,000 after acquiring an additional 225 shares during the period. Deutsche Bank AG lifted its position in shares of HealthEquity by 25.9% during the 4th quarter. Deutsche Bank AG now owns 118,199 shares of the company's stock valued at $11,341,000 after acquiring an additional 24,289 shares during the period. Ethic Inc. bought a new stake in shares of HealthEquity during the 4th quarter valued at $341,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of HealthEquity by 4.6% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 114,886 shares of the company's stock valued at $11,023,000 after acquiring an additional 5,080 shares during the period. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.